{"ticker": {"uuid": "4e1a6c6d-a9b7-4994-8b4a-0b7d15281a05", "symbol": "CVRX", "name": "CVRx Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing", "summary": "CVRx Inc, listed on Nasdaq, specializes in developing neurostimulation devices like Barostim for patients with heart failure and hypertension whose symptoms are difficult to control with conventional therapies. The company's business model relies on partnerships with cardiologist", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cvrx-inc-focuses-on-heart-failure-devices-as-investors-watch-nasdaq/69725421", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:09:23", "published_display": "08 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc(CVRX) Stock Options Chain | Quotes & News", "summary": "This article provides access to the stock options chain, quotes, and news for CVRx Inc (CVRX). It serves as a financial information resource for investors interested in the company's stock performance and related options data.", "url": "https://www.moomoo.com/stock/CVRX-US/options-chain?chain_id=Name1K9-3FXPhg.1kufep0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2FHELE-US%22%7D", "source_name": "Moomoo", "published_at": "2026-07-08T02:09:23", "published_display": "08 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc focuses on cardiovascular innovation amid thin market signals", "summary": "CVRx Inc, a US medical technology company, specializes in neuromodulation therapies for chronic heart failure and hypertension, targeting patients whose conditions are not controlled by conventional treatments. The company develops implantable systems, such as those for barorefle", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cvrx-inc-focuses-on-cardiovascular-innovation-amid-thin-market-signals/69717220", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T21:33:00", "published_display": "07 Jul 2026 21:33", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14", "summary": "Lake Street has reiterated its Buy rating for CVRx Inc (CVRX.US) and maintained its target price of $14. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The report suggests confidence in CVRx Inc's future ", "url": "https://www.moomoo.com/news/post/72526499/lake-street-maintains-cvrx-inc-cvrxus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-07T02:39:35", "published_display": "07 Jul 2026 02:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(CVRX) Risk Channels and Responsive Allocation", "summary": "This article analyzes Cvrx Inc. (NASDAQ: CVRX) using AI models, identifying a mixed sentiment alignment and a mid-channel oscillation pattern. It highlights an exceptional short setup with a 91.5:1 risk-reward ratio, targeting a 28.1% downside. The analysis provides specific trad", "url": "https://news.stocktradersdaily.com/news_release/16/CVRX_Risk_Channels_and_Responsive_Allocation_070626051402_1783372442.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-06T17:14:49", "published_display": "06 Jul 2026 17:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article focuses on the enterprise value to EBIT forward for CVRx, Inc. (NASDAQ: CVRX). It presents a snapshot of the company's financial data on TradingView, indicating that the market is closed at the time of viewing. The content primarily highlights where to find this finan", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T01:39:16", "published_display": "05 Jul 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX,INVA Volatility & Greeks", "summary": "This article provides a detailed financial overview of two companies, CVRx Inc. (CVRX) and Innoviva Inc. (INVA), including their stock performance, market capitalization, key financial ratios, and analyst recommendations. It lists various metrics such as volatility, EPS, sales gr", "url": "https://finviz.com/stock?t=CVRX%2CINVA&p=d&ty=ocv&e=2026-02-20&ov=list_date", "source_name": "Finviz", "published_at": "2026-07-04T12:13:32", "published_display": "04 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article presents information regarding the enterprise value to forward revenue for CVRx, Inc. (NASDAQ: CVRX). It is a finance-related snippet from TradingView, focusing on the company's financials within the health technology sector. The content appears to be a stub or a sect", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T22:10:41", "published_display": "28 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article provides information regarding the forward price-to-earnings ratio for CVRx, Inc. (NASDAQ: CVRX) within the TradingView platform. It shows the navigation path to access this financial data and emphasizes that the market was closed with no trades at the time of viewing", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:40:24", "published_display": "28 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "This article displays information regarding the \"Price to book forward\" metric for CVRx, Inc. (NASDAQ: CVRX) on TradingView. It indicates that the data is provided by human input and is available in English. The page is part of TradingView's financial data section for CVRx, Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:40:04", "published_display": "28 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX)", "summary": "This article provides an overview of CVRx, Inc. (NASDAQ:CVRX) stock performance, financial actuals, and analyst estimates. It highlights the current stock price, recent changes, market capitalization, and future earnings expectations, along with historical data like all-time high", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:40:32", "published_display": "26 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Institutional Confidence", "summary": "The article analyzes the institutional confidence in CVRx Inc (CVRX), revealing a current institutional shareholding score of 5.00, placing it 109th out of 203 in its industry. The institutional shareholding proportion decreased by 19.00% quarter-over-quarter to 65.53%. Bill Nygr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-25T10:11:32", "published_display": "25 Jun 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Stock Forecast & Analyst Ratings", "summary": "This article provides a stock forecast and analyst ratings for CVRx Inc (CVRX). It likely includes insights into the company's financial performance, market position, and future outlook based on expert analysis, offering guidance for potential investors or current shareholders.", "url": "https://www.moomoo.com/stock/CVRX-US/forecast?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2F4197-BMS%22%7D", "source_name": "Moomoo", "published_at": "2026-06-25T08:40:32", "published_display": "25 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of CVRx Inc (CVRX), detailing its current price momentum score, support and resistance levels, and various technical indicators and moving averages. The analysis suggests the stock is currently trading between a resistance level of 6.00 ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/technical", "source_name": "TradingKey", "published_at": "2026-06-18T20:39:55", "published_display": "18 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis", "summary": "CVRx Inc (CVRX) currently holds a financial score of 6.70, placing it 140th out of 203 companies in the Healthcare Equipment & Supplies industry. The company's financial status is stable, though its operating efficiency is noted as low. In its latest quarter, CVRx Inc reported a ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:51", "published_display": "18 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for CVRx Inc (CVRX), showing its revenue by region. As of the last update on April 6, CVRx Inc's total revenue was $51.88 million from the US and $4.77 million from Europe, making up 91.58% and 8.42% of its revenue respectively. The artic", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T00:41:18", "published_display": "18 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating", "summary": "Craig-Hallum has reiterated its Buy rating on CVRx Inc (CVRX.US). The article does not provide further details regarding the rationale behind this rating or any financial analysis.", "url": "https://www.moomoo.com/news/post/71278418/craig-hallum-maintains-cvrx-inc-cvrxus-with-buy-rating", "source_name": "Moomoo", "published_at": "2026-06-10T03:10:11", "published_display": "10 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx CFO Jared Oasheim to step down after decade with company", "summary": "Jared Oasheim, CFO of CVRx, Inc. (NASDAQ:CVRX), will be stepping down from his position after a decade with the company to pursue other professional opportunities. Oasheim, who played a key role in the company's IPO and establishing its financial organization, will remain until a", "url": "https://www.investing.com/news/company-news/cvrx-cfo-jared-oasheim-to-step-down-after-decade-with-company-93CH-4732629", "source_name": "Investing.com", "published_at": "2026-06-09T14:39:47", "published_display": "09 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Announces Chief Financial Officer Transition", "summary": "CVRx, Inc. (NASDAQ: CVRX) announced that Jared Oasheim, its Chief Financial Officer, will be stepping down to pursue other professional opportunities. Mr. Oasheim will remain with the company until a successor is appointed and act as an advisor until February 2027 to ensure a smo", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/GlobeNewswire/2374772/cvrx-announces-chief-financial-officer-transition/", "source_name": "The Globe and Mail", "published_at": "2026-06-09T11:38:44", "published_display": "09 Jun 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdnlmaUxKd2gyUzQwM0g1dFV4WGlPOHdsQWpkWXlvczM2Q292Vml0SkhFYUJEbFplME5YazRWN091UGdNZlB4eU43Z2lmTjZUOTlSTnJiVTlGOElpZXV4Ml9rRTJBSkdMMlNnTjdXOEZ4cVV4M3dINEkzc1Y4UnUzVlVyZE1ZYWhlcEIyRW1Gd0xfTGVGQjRsTzdFeFNWZ2U0RWVIWjN3?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx (CVRX) Q1 Loss Of US$13.1 Million Tests Bullish Revenue Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion Potential", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cvrx-inc-cvrx-q1-2026-070644077.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T07:06:44+00:00", "published_display": "12 May 2026 07:06", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcTRubTRiQTJPUExKMDhrLXBIY01mbEVHd2pnbklkeVlLNlBLa2V3RUdQcWM4d0Y4WEtQNThIaEZxc090ZUVqSjI5VjJheXE2dko5VUNtbmgyZUNVdnFWWm1Xa3U1N0s4elYxNG5ENlBYdHBXTi1oaFY1aGo0TkZEMzBTTDg2UkpkRmNBcGVDZEMydTIxN1NRVTJqMWJxVTVjN3F1QWM1aEhuajg2REFkU081WThNemYyeEJIeTFXZ0x1ekJqQkpldTVGZ3JpdjJaOE4teXRValFNdlVzbkVXY2d3?oc=5", "source_name": "ChartMill", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "CVRx, Inc. Financial Statements \u2013 NASDAQ:CVRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5jVGxfWnJCMnVPcXBodWNkckEzMmJFN1prMEJ6Rkg5NTV3amVHdl9iNGRETk9HVm05djFUZ3ZjMVE1X0oxY1hCNmNiU1NwV2pTY2lQOWxjcHp5ZnhGVmtGdmRidXVsOXRVTkZMWmt0WDlYeWdvYmZn?oc=5", "source_name": "TradingView", "published_at": "2021-06-29T16:04:28+00:00", "published_display": "29 Jun 2021 16:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX Stock Price and Chart \u2014 NASDAQ:CVRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9weXU5c3RvVl9EZXlYd2FReWF6UTFFRDNfUXc4X21UZjBQOFJRNWdvMTNPRWJtWURtRnR5emlkdjVHRWRZR0VxLW1lQ0tMV3AwMHpaUk1zSVQzZ1gx?oc=5", "source_name": "TradingView", "published_at": "2021-06-29T16:01:35+00:00", "published_display": "29 Jun 2021 16:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing", "summary": "CVRx Inc, listed on Nasdaq, specializes in developing neurostimulation devices like Barostim for patients with heart failure and hypertension whose symptoms are difficult to control with conventional therapies. The company's business model relies on partnerships with cardiologist", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cvrx-inc-focuses-on-heart-failure-devices-as-investors-watch-nasdaq/69725421", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:09:23", "published_display": "08 Jul 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc(CVRX) Stock Options Chain | Quotes & News", "summary": "This article provides access to the stock options chain, quotes, and news for CVRx Inc (CVRX). It serves as a financial information resource for investors interested in the company's stock performance and related options data.", "url": "https://www.moomoo.com/stock/CVRX-US/options-chain?chain_id=Name1K9-3FXPhg.1kufep0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2FHELE-US%22%7D", "source_name": "Moomoo", "published_at": "2026-07-08T02:09:23", "published_display": "08 Jul 2026 02:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc focuses on cardiovascular innovation amid thin market signals", "summary": "CVRx Inc, a US medical technology company, specializes in neuromodulation therapies for chronic heart failure and hypertension, targeting patients whose conditions are not controlled by conventional treatments. The company develops implantable systems, such as those for barorefle", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cvrx-inc-focuses-on-cardiovascular-innovation-amid-thin-market-signals/69717220", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T21:33:00", "published_display": "07 Jul 2026 21:33", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14", "summary": "Lake Street has reiterated its Buy rating for CVRx Inc (CVRX.US) and maintained its target price of $14. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and valuation. The report suggests confidence in CVRx Inc's future ", "url": "https://www.moomoo.com/news/post/72526499/lake-street-maintains-cvrx-inc-cvrxus-with-buy-rating-maintains", "source_name": "Moomoo", "published_at": "2026-07-07T02:39:35", "published_display": "07 Jul 2026 02:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(CVRX) Risk Channels and Responsive Allocation", "summary": "This article analyzes Cvrx Inc. (NASDAQ: CVRX) using AI models, identifying a mixed sentiment alignment and a mid-channel oscillation pattern. It highlights an exceptional short setup with a 91.5:1 risk-reward ratio, targeting a 28.1% downside. The analysis provides specific trad", "url": "https://news.stocktradersdaily.com/news_release/16/CVRX_Risk_Channels_and_Responsive_Allocation_070626051402_1783372442.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-06T17:14:49", "published_display": "06 Jul 2026 17:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article focuses on the enterprise value to EBIT forward for CVRx, Inc. (NASDAQ: CVRX). It presents a snapshot of the company's financial data on TradingView, indicating that the market is closed at the time of viewing. The content primarily highlights where to find this finan", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T01:39:16", "published_display": "05 Jul 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX,INVA Volatility & Greeks", "summary": "This article provides a detailed financial overview of two companies, CVRx Inc. (CVRX) and Innoviva Inc. (INVA), including their stock performance, market capitalization, key financial ratios, and analyst recommendations. It lists various metrics such as volatility, EPS, sales gr", "url": "https://finviz.com/stock?t=CVRX%2CINVA&p=d&ty=ocv&e=2026-02-20&ov=list_date", "source_name": "Finviz", "published_at": "2026-07-04T12:13:32", "published_display": "04 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article presents information regarding the enterprise value to forward revenue for CVRx, Inc. (NASDAQ: CVRX). It is a finance-related snippet from TradingView, focusing on the company's financials within the health technology sector. The content appears to be a stub or a sect", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T22:10:41", "published_display": "28 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "The article provides information regarding the forward price-to-earnings ratio for CVRx, Inc. (NASDAQ: CVRX) within the TradingView platform. It shows the navigation path to access this financial data and emphasizes that the market was closed with no trades at the time of viewing", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:40:24", "published_display": "28 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of CVRx, Inc. \u2013 NASDAQ:CVRX", "summary": "This article displays information regarding the \"Price to book forward\" metric for CVRx, Inc. (NASDAQ: CVRX) on TradingView. It indicates that the data is provided by human input and is available in English. The page is part of TradingView's financial data section for CVRx, Inc.", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:40:04", "published_display": "28 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX)", "summary": "This article provides an overview of CVRx, Inc. (NASDAQ:CVRX) stock performance, financial actuals, and analyst estimates. It highlights the current stock price, recent changes, market capitalization, and future earnings expectations, along with historical data like all-time high", "url": "https://www.tradingview.com/symbols/NASDAQ-CVRX/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:40:32", "published_display": "26 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Institutional Confidence", "summary": "The article analyzes the institutional confidence in CVRx Inc (CVRX), revealing a current institutional shareholding score of 5.00, placing it 109th out of 203 in its industry. The institutional shareholding proportion decreased by 19.00% quarter-over-quarter to 65.53%. Bill Nygr", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/sentiment", "source_name": "TradingKey", "published_at": "2026-06-25T10:11:32", "published_display": "25 Jun 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Stock Forecast & Analyst Ratings", "summary": "This article provides a stock forecast and analyst ratings for CVRx Inc (CVRX). It likely includes insights into the company's financial performance, market position, and future outlook based on expert analysis, offering guidance for potential investors or current shareholders.", "url": "https://www.moomoo.com/stock/CVRX-US/forecast?chain_id=Name1K9-3FXPhg.1l0a440&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A57,%22f%22%3A%22www.moomoo.com%2Fstock%2F4197-BMS%22%7D", "source_name": "Moomoo", "published_at": "2026-06-25T08:40:32", "published_display": "25 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of CVRx Inc (CVRX), detailing its current price momentum score, support and resistance levels, and various technical indicators and moving averages. The analysis suggests the stock is currently trading between a resistance level of 6.00 ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/technical", "source_name": "TradingKey", "published_at": "2026-06-18T20:39:55", "published_display": "18 Jun 2026 20:39", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis", "summary": "CVRx Inc (CVRX) currently holds a financial score of 6.70, placing it 140th out of 203 companies in the Healthcare Equipment & Supplies industry. The company's financial status is stable, though its operating efficiency is noted as low. In its latest quarter, CVRx Inc reported a ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T10:10:51", "published_display": "18 Jun 2026 10:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for CVRx Inc (CVRX), showing its revenue by region. As of the last update on April 6, CVRx Inc's total revenue was $51.88 million from the US and $4.77 million from Europe, making up 91.58% and 8.42% of its revenue respectively. The artic", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cvrx/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T00:41:18", "published_display": "18 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating", "summary": "Craig-Hallum has reiterated its Buy rating on CVRx Inc (CVRX.US). The article does not provide further details regarding the rationale behind this rating or any financial analysis.", "url": "https://www.moomoo.com/news/post/71278418/craig-hallum-maintains-cvrx-inc-cvrxus-with-buy-rating", "source_name": "Moomoo", "published_at": "2026-06-10T03:10:11", "published_display": "10 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx CFO Jared Oasheim to step down after decade with company", "summary": "Jared Oasheim, CFO of CVRx, Inc. (NASDAQ:CVRX), will be stepping down from his position after a decade with the company to pursue other professional opportunities. Oasheim, who played a key role in the company's IPO and establishing its financial organization, will remain until a", "url": "https://www.investing.com/news/company-news/cvrx-cfo-jared-oasheim-to-step-down-after-decade-with-company-93CH-4732629", "source_name": "Investing.com", "published_at": "2026-06-09T14:39:47", "published_display": "09 Jun 2026 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Announces Chief Financial Officer Transition", "summary": "CVRx, Inc. (NASDAQ: CVRX) announced that Jared Oasheim, its Chief Financial Officer, will be stepping down to pursue other professional opportunities. Mr. Oasheim will remain with the company until a successor is appointed and act as an advisor until February 2027 to ensure a smo", "url": "https://www.theglobeandmail.com/investing/markets/markets-news/GlobeNewswire/2374772/cvrx-announces-chief-financial-officer-transition/", "source_name": "The Globe and Mail", "published_at": "2026-06-09T11:38:44", "published_display": "09 Jun 2026 11:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPdnlmaUxKd2gyUzQwM0g1dFV4WGlPOHdsQWpkWXlvczM2Q292Vml0SkhFYUJEbFplME5YazRWN091UGdNZlB4eU43Z2lmTjZUOTlSTnJiVTlGOElpZXV4Ml9rRTJBSkdMMlNnTjdXOEZ4cVV4M3dINEkzc1Y4UnUzVlVyZE1ZYWhlcEIyRW1Gd0xfTGVGQjRsTzdFeFNWZ2U0RWVIWjN3?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx (CVRX) Q1 Loss Of US$13.1 Million Tests Bullish Revenue Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion Potential", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cvrx-inc-cvrx-q1-2026-070644077.html", "source_name": "GuruFocus.com", "published_at": "2026-05-12T07:06:44+00:00", "published_display": "12 May 2026 07:06", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxQcTRubTRiQTJPUExKMDhrLXBIY01mbEVHd2pnbklkeVlLNlBLa2V3RUdQcWM4d0Y4WEtQNThIaEZxc090ZUVqSjI5VjJheXE2dko5VUNtbmgyZUNVdnFWWm1Xa3U1N0s4elYxNG5ENlBYdHBXTi1oaFY1aGo0TkZEMzBTTDg2UkpkRmNBcGVDZEMydTIxN1NRVTJqMWJxVTVjN3F1QWM1aEhuajg2REFkU081WThNemYyeEJIeTFXZ0x1ekJqQkpldTVGZ3JpdjJaOE4teXRValFNdlVzbkVXY2d3?oc=5", "source_name": "ChartMill", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRx, Inc. Financial Statements \u2013 NASDAQ:CVRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE5jVGxfWnJCMnVPcXBodWNkckEzMmJFN1prMEJ6Rkg5NTV3amVHdl9iNGRETk9HVm05djFUZ3ZjMVE1X0oxY1hCNmNiU1NwV2pTY2lQOWxjcHp5ZnhGVmtGdmRidXVsOXRVTkZMWmt0WDlYeWdvYmZn?oc=5", "source_name": "TradingView", "published_at": "2021-06-29T16:04:28+00:00", "published_display": "29 Jun 2021 16:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CVRX Stock Price and Chart \u2014 NASDAQ:CVRX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE9weXU5c3RvVl9EZXlYd2FReWF6UTFFRDNfUXc4X21UZjBQOFJRNWdvMTNPRWJtWURtRnR5emlkdjVHRWRZR0VxLW1lQ0tMV3AwMHpaUk1zSVQzZ1gx?oc=5", "source_name": "TradingView", "published_at": "2021-06-29T16:01:35+00:00", "published_display": "29 Jun 2021 16:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 99, "total_relevant": 36, "sentiment_summary": {"positive": 7, "negative": 2, "neutral": 27, "score": 53, "total": 36, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 78, "events": [{"event": "earnings", "label": "Earnings", "weight": 9.49, "count": 20}, {"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 5.43, "latest_week": "2026-07-10", "one_week_move": -3.0, "four_week_move": 8.0, "twelve_week_move": -26.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.939239, "market_dynamics_buy_signal": false, "relative_strength": -39.191036, "fair_value_gap": -54.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.0446, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.0% over one week, +8.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "TradingView", "count": 7}, {"label": "Moomoo", "count": 4}, {"label": "TradingKey", "count": 4}, {"label": "AD HOC NEWS", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Stock Traders Daily", "count": 1}, {"label": "Finviz", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 20}, {"label": "Market update", "count": 13}, {"label": "Analyst action", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.0% over one week, +8.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "CVRx Inc focuses on heart failure devices as investors watch Nasdaq listing"}], "updated_at": "2026-07-17T05:44:18.193151+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}